Global Life Science Ventures Investing in the life sciences

Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.

Text size

Track record

a proactive syndicate player
investment in high-potential companies

Over the years, GLSV has established a sound track record through discerning investments in high-potential companies. After registration of the original fund in 1996, the available capital of Euro 66 million has been invested in first and follow-on financing rounds of 18 ventures active in the life sciences.

The positive development of the first fund has been highlighted by successful exits and merger & acquisition transactions. The second fund is being used to finance further promising companies that operate in significant markets with considerable upside potential.

The latest news on our investments from both funds is available in our our News & Events section.